Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published March 5, 2014 | Supplemental Material + Published
Journal Article Open

Design of Sequence-Specific DNA Binding Molecules for DNA Methyltransferase Inhibition

Abstract

The CpG dyad, an important genomic feature in DNA methylation and transcriptional regulation, is an attractive target for small molecules. To assess the utility of minor groove binding oligomers for CpG recognition, we screened a small library of hairpin pyrrole-imidazole polyamides targeting the sequence 5′-CGCG-3′ and assessed their sequence specificity using an unbiased next-generation sequencing assay. Our findings indicate that hairpin polyamide of sequence PyImβIm-γ-PyImβIm (1), previously identified as a high affinity 5′-CGCG-3′ binder, favors 5′-GCGC-3′ in an unanticipated reverse binding orientation. Replacement of one β alanine with Py to afford PyImPyIm-γ-PyImβIm (3) restores the preference for 5′-CGCG-3′ binding in a forward orientation. The minor groove binding hairpin 3 inhibits DNA methyltransferase activity in the major groove at its target site more effectively than 1, providing a molecular basis for design of sequence-specific antagonists of CpG methylation.

Additional Information

© 2014 American Chemical Society. ACS AuthorChoice. Received: January 10, 2014. Publication Date (Web): February 6, 2014. Sequencing was conducted at the Millard and Muriel Jacobs Genetics and Genomics Laboratory at the California Institute of Technology. Mass spectrometry analyses were performed in the Mass Spectrometry Laboratory of the Division of Chemistry and Chemical Engineering at the California Institute of Technology. Gels were scanned in the Center for the Chemistry of Cellular Signaling at the California Institute of Technology. National Institutes of Health (grant numbers GM51747 and GM27681); Tobacco-Related Disease Research Program (award number 20DT-0037 to J.S.K., dissertation research award); American Cancer Society (grant number PF-10-015-01-CDD to J.L.M., postdoctoral fellowship). Funding for open access charge: National Institutes of Health (grant number GM51747). The authors declare no competing financial interest.

Attached Files

Published - ja500211z.pdf

Supplemental Material - ja500211z_si_001.pdf

Files

ja500211z.pdf
Files (3.0 MB)
Name Size Download all
md5:b4e0156e4b4751cbb08f0e7d411d075b
2.4 MB Preview Download
md5:7a91b521c408d662803ef8977a643886
621.3 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 26, 2023